Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Biochemistry ; 56(41): 5615-5622, 2017 10 17.
Article in English | MEDLINE | ID: mdl-28898049

ABSTRACT

Chloroquine (CQ) resistance (CQR) in Plasmodium falciparum malaria is widespread and has limited the use of CQ in many regions of the globe. Malaria caused by the related human parasite P. vivax is as widespread as is P. falciparum malaria and has been treated with CQ as extensively as has P. falciparum, suggesting that P. vivax parasites have been selected with CQ as profoundly as have P. falciparum parasites. Indeed, a growing number of clinical reports have presented data suggesting increased P. vivax CQR. Cytostatic (growth inhibitory) CQR for P. falciparum is caused by Plasmodium falciparum chloroquine resistance transporter (PfCRT) mutations, and it has been proposed that mutations in the PvCRT orthologue may simliarly cause P. vivax CQR via increasing CQ transport from the P. vivax digestive vacuole. Here we report the first quantitative analysis of drug transport mediated by all known mutant isoforms of Plasmodium vivax chloroquine resistance transporter (PvCRT) in order to test the protein's potential link to growing P. vivax CQR phenomena. Small, but statistically significant, differences in the transport of CQ and other quinoline antimalarial drugs were found for multiple PvCRT isoforms, relative to wild type PvCRT, suggesting that mutations in PvCRT can contribute to P. vivax CQR and other examples of quinoline antimalarial drug resistance.


Subject(s)
Antimalarials/metabolism , Chloroquine/metabolism , Membrane Transport Proteins/metabolism , Models, Molecular , Mutation , Plasmodium vivax/metabolism , Protozoan Proteins/metabolism , Amino Acid Substitution , Antimalarials/pharmacology , Biological Transport , Cell Membrane/drug effects , Cell Membrane/metabolism , Chloroquine/pharmacology , Colony Count, Microbial , Drug Resistance , Humans , Malaria, Vivax/drug therapy , Malaria, Vivax/parasitology , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/genetics , Mutagenesis, Site-Directed , Plasmodium vivax/drug effects , Plasmodium vivax/growth & development , Plasmodium vivax/isolation & purification , Primaquine/metabolism , Primaquine/pharmacology , Protein Conformation , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Tritium
2.
PLoS Pathog ; 12(11): e1005976, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27832198

ABSTRACT

Southeast Asia is an epicenter of multidrug-resistant Plasmodium falciparum strains. Selective pressures on the subcontinent have recurrently produced several allelic variants of parasite drug resistance genes, including the P. falciparum chloroquine resistance transporter (pfcrt). Despite significant reductions in the deployment of the 4-aminoquinoline drug chloroquine (CQ), which selected for the mutant pfcrt alleles that halted CQ efficacy decades ago, the parasite pfcrt locus is continuously evolving. This is highlighted by the presence of a highly mutated allele, Cam734 pfcrt, which has acquired the singular ability to confer parasite CQ resistance without an associated fitness cost. Here, we used pfcrt-specific zinc-finger nucleases to genetically dissect this allele in the pathogenic setting of asexual blood-stage infection. Comparative analysis of drug resistance and growth profiles of recombinant parasites that express Cam734 or variants thereof, Dd2 (the most common Southeast Asian variant), or wild-type pfcrt, revealed previously unknown roles for PfCRT mutations in modulating parasite susceptibility to multiple antimalarial agents. These results were generated in the GC03 strain, used in multiple earlier pfcrt studies, and might differ in natural isolates harboring this allele. Results presented herein show that Cam734-mediated CQ resistance is dependent on the rare A144F mutation that has not been observed beyond Southeast Asia, and reveal distinct impacts of this and other Cam734-specific mutations on CQ resistance and parasite growth rates. Biochemical assays revealed a broad impact of mutant PfCRT isoforms on parasite metabolism, including nucleoside triphosphate levels, hemoglobin catabolism and disposition of heme, as well as digestive vacuole volume and pH. Results from our study provide new insights into the complex molecular basis and physiological impact of PfCRT-mediated antimalarial drug resistance, and inform ongoing efforts to characterize novel pfcrt alleles that can undermine the efficacy of first-line antimalarial drug regimens.


Subject(s)
Drug Resistance/genetics , Genetic Fitness/genetics , Malaria, Falciparum/genetics , Membrane Transport Proteins/genetics , Plasmodium falciparum/physiology , Protozoan Proteins/genetics , Aminoquinolines/pharmacology , Antimalarials/pharmacology , Genotype , Humans , Mass Spectrometry , Microbial Sensitivity Tests , Mutation , Vacuoles/metabolism
3.
Malar J ; 15: 186, 2016 Mar 31.
Article in English | MEDLINE | ID: mdl-27036417

ABSTRACT

BACKGROUND: Recent work has perfected yeast-based methods for measuring drug transport by the Plasmodium falciparum chloroquine (CQ) resistance transporter (PfCRT). METHODS: The approach relies on inducible heterologous expression of PfCRT in Saccharomyces cerevisiae yeast. In these experiments selecting drug concentrations are not toxic to the yeast, nor is expression of PfCRT alone toxic. Only when PfCRT is expressed in the presence of CQ is the growth of yeast impaired, due to inward transport of chloroquine (CQ) via the transporter. RESULTS: During analysis of all 53 known naturally occurring PfCRT isoforms, two isoforms (PH1 and PH2 PfCRT) were found to be intrinsically toxic to yeast, even in the absence of CQ. Additional analysis of six very recently identified PfCRT isoforms from Malaysia also showed some toxicity. In this paper the nature of this yeast toxicity is examined. Data also show that PH1 and PH2 isoforms of PfCRT transport CQ with an efficiency intermediate to that catalyzed by previously studied CQR conferring isoforms. Mutation of PfCRT at position 160 is found to perturb vacuolar physiology, suggesting a fitness cost to position 160 amino acid substitutions. CONCLUSION: These data further define the wide range of activities that exist for PfCRT isoforms found in P. falciparum isolates from around the globe.


Subject(s)
Membrane Transport Proteins/toxicity , Protein Isoforms/toxicity , Protozoan Proteins/toxicity , Recombinant Proteins/toxicity , Saccharomyces cerevisiae/physiology , Vacuoles/physiology , Chloroquine/metabolism , Malaysia , Membrane Transport Proteins/genetics , Protein Isoforms/genetics , Protozoan Proteins/genetics , Recombinant Proteins/genetics , Saccharomyces cerevisiae/genetics
4.
Biochemistry ; 54(32): 5083-94, 2015 Aug 18.
Article in English | MEDLINE | ID: mdl-26208441

ABSTRACT

At least 53 distinct isoforms of Plasmodium falciparum chloroquine resistance transporter (PfCRT) protein are expressed in strains or isolates of P. falciparum malarial parasites from around the globe. These parasites exhibit a range of sensitivities to chloroquine (CQ) and other drugs. Mutant PfCRT is believed to confer cytostatic CQ resistance (CQR(CS)) by transporting CQ away from its DV target (free heme released upon hemoglobin digestion). One theory is that variable CQ transport catalyzed by these different PfCRT isoforms is responsible for the range of CQ sensitivities now found for P. falciparum. Alternatively, additional mutations in drug-selected parasites, or additional functions of PfCRT, might complement PfCRT-mediated CQ transport in conferring the range of observed resistance phenotypes. To distinguish between these possibilities, we recently optimized a convenient method for measuring PfCRT-mediated CQ transport, involving heterologous expression in Saccharomyces cerevisiae. Here, we use this method to quantify drug transport activity for 45 of 53 of the naturally occurring PfCRT isoforms. Data show that variable levels of CQR likely depend upon either additional PfCRT functions or additional genetic events, including perhaps changes that influence DV membrane potential. The data also suggest that the common K76T PfCRT mutation that is often used to distinguish a P. falciparum CQR phenotype is not, in and of itself, a fully reliable indicator of CQR status.


Subject(s)
Chloroquine/metabolism , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/metabolism , Plasmodium falciparum/metabolism , Protozoan Proteins/chemistry , Protozoan Proteins/metabolism , Amino Acid Sequence , Antimalarials/metabolism , Antimalarials/pharmacology , Base Sequence , Biological Transport, Active , Chloroquine/pharmacology , DNA, Protozoan/genetics , Drug Resistance/genetics , Genes, Protozoan , Kinetics , Membrane Transport Proteins/genetics , Models, Molecular , Molecular Sequence Data , Mutation , Phenotype , Plasmodium falciparum/drug effects , Plasmodium falciparum/genetics , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protozoan Proteins/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Sequence Homology, Amino Acid
5.
J Biol Chem ; 288(31): 22576-83, 2013 Aug 02.
Article in English | MEDLINE | ID: mdl-23754276

ABSTRACT

A representative of a new class of potent antimalarials with an unknown mode of action was recently described. To identify the molecular target of this class of antimalarials, we employed a photo-reactive affinity capture method to find parasite proteins specifically interacting with the capture compound in living parasitized cells. The capture reagent retained the antimalarial properties of the parent molecule (ACT-213615) and accumulated within parasites. We identified several proteins interacting with the capture compound and established a functional interaction between ACT-213615 and PfMDR1. We surmise that PfMDR1 may play a role in the antimalarial activity of the piperazine-containing compound ACT-213615.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/physiology , Antimalarials/pharmacology , Plasmodium falciparum/physiology , Ultraviolet Rays , Animals
6.
Biochemistry ; 52(24): 4242-9, 2013 Jun 18.
Article in English | MEDLINE | ID: mdl-23688277

ABSTRACT

The function of Plasmodium falciparum chloroquine resistance transporter (PfCRT) can be quantified using a Saccharomyces cerevisiae model system [Baro, N. K., Pooput, C., and Roepe, P. D. (2011) Biochemistry 50, 6701-6710]. We further optimized this system to distinguish PfCRT isoforms found in P. falciparum strains and isolates from across the globe. We created and expressed 13 naturally occurring pfcrt alleles associated with a range of chloroquine resistant (CQR) phenotypes. Using galactose induction of PfCRT, we quantified PfCRT and chloroquine (CQ)-dependent yeast growth inhibition and [3H]CQ transport specifically due to a given PfCRT isoform. Surprisingly, we found poor correlation between these parameters and the CQ IC50 observed in strains of malaria harboring the same isoforms. This suggested that an increased level of CQ transport due to PfCRT mutation is necessary, but not sufficient, for the range of CQ IC50 values observed in globally distributed CQR P. falciparum isolates.


Subject(s)
Chloroquine/pharmacology , Membrane Transport Proteins/metabolism , Plasmodium falciparum/metabolism , Protozoan Proteins/metabolism , Alleles , Base Sequence , Chemistry, Pharmaceutical , Chloroquine/chemistry , Drug Design , Galactose/chemistry , Haplotypes , Inhibitory Concentration 50 , Membrane Transport Proteins/genetics , Molecular Sequence Data , Mutation , Phenotype , Plasmids/metabolism , Plasmodium falciparum/genetics , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protozoan Proteins/genetics , Saccharomyces cerevisiae/metabolism
7.
Soc Psychiatry Psychiatr Epidemiol ; 47(9): 1489-98, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22113717

ABSTRACT

BACKGROUND: The war in northern Uganda has had a debilitating effect on the mental health of children and adolescents in the population. This study measures the prevalence and considers the aetiology of psychological distress in war-affected adolescents 4 years after the end of the conflict. METHODS: This is a cross-sectional study of 205 adolescents, aged 12-19, from a boarding primary school in Gulu, northern Uganda. A war experiences checklist was developed with the assistance of local professionals. The Impact of Event Scale-Revised (IES-R) measured post-traumatic stress symptoms. Finally, the Acholi Psychosocial Assessment Instrument (APAI) was used to measure locally described mental health constructs similar to the Western concepts of depression and anxiety. RESULTS: Four years after the end of the war, 57% of the students were still found to have clinically significant levels of post-traumatic stress symptoms using a similar cut-off score to previous studies among the same population. Both components of traumatic exposure: (i) the number of types of traumatic event experienced; and (ii) whether the adolescent was abducted were significantly associated with psychological distress. There was a strong correlation between post-traumatic stress symptoms and internalising symptoms. CONCLUSION: War-affected adolescents may continue to suffer from significant psychological stress in the years following the cessation of conflict. Multiple exposure to a number of different types of traumatic event may directly increase the likelihood of psychological distress especially for those exposed to the most extreme violence. The feasibility of employing a locally developed and validated screening instrument is demonstrated. Implications for future research and intervention in post-conflict areas are considered.


Subject(s)
Mass Screening , Stress Disorders, Post-Traumatic/diagnosis , Stress, Psychological/diagnosis , Violence/psychology , Warfare , Adolescent , Anxiety/epidemiology , Anxiety/etiology , Anxiety/psychology , Checklist , Child , Cross-Sectional Studies , Depression/epidemiology , Depression/etiology , Depression/psychology , Female , Humans , Male , Mass Screening/methods , Mental Health , Prevalence , Psychiatric Status Rating Scales , Psychometrics , Risk Factors , Schools , Sex Distribution , Socioeconomic Factors , Stress Disorders, Post-Traumatic/epidemiology , Stress Disorders, Post-Traumatic/psychology , Stress, Psychological/epidemiology , Stress, Psychological/psychology , Surveys and Questionnaires , Uganda/epidemiology , Violence/statistics & numerical data , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...